The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
about
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesThe treatment landscape in thyroid cancer: a focus on cabozantinibManagement Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerEfficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupMedullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions.Multikinase inhibitors use in differentiated thyroid carcinoma.Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experienceTreating medullary thyroid cancer in the age of targeted therapy.Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer.Evolving approaches to patients with advanced differentiated thyroid cancerOptimal differentiated thyroid cancer management in the elderly.PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.The management of metastatic radioiodine-refractory differentiated thyroid cancer requires an integrated approach including both directed and systemic therapies.Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient.Follicular cell-derived thyroid cancer.Targeted Therapy for Medullary Thyroid Cancer: A Review.Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.[Differentiated thyroid cancer].Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center.Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.
P2860
Q26751274-8E0FBBFC-9393-4C23-ADC7-21056B8D5F29Q26796404-FC44B886-B1F4-4F73-83CF-8BAFB59679ACQ26829349-ED625730-A3FF-4322-962E-C85FD6572BC9Q30367068-E30B5C04-BCAE-4D67-A27F-13F36772AADFQ33577870-84C7322E-FB0F-415D-A1F4-8C95F2C887F1Q33587905-F966B1E4-C0F2-4D9C-B3B0-56A2F7C7D7C4Q34628424-FE992BEB-C8FE-4420-A5D7-9984EEFEB93FQ34660901-CE035B31-4020-4FBF-ADCE-1C715E64403BQ34810764-285ED9D1-2B31-4129-847D-28000D1B071BQ35509932-9447ED93-29F4-4257-BBED-23AD01C140B3Q36037051-763F19C1-6553-4924-B8AC-103AD60CBE54Q36864736-4AEC4DFD-F2A3-4B95-86EA-06113E3F676FQ38396892-F9228B71-A8B1-44F1-AEBA-5918DC91AA43Q38644584-8DB2CFA3-FB4D-4B56-A427-A1C848788DE2Q41999750-F765E299-65C6-4140-817C-23C4025A0C1CQ47107422-0D78E72C-9455-44DA-B5DC-10E1A60B96E0Q48651339-11631EBA-CF30-4EE0-A9B4-ACB081DA6DA5Q49328959-F1030404-D4DC-42ED-A13B-95431EC30E71Q49592440-1FC19A5E-92DA-4AC3-994E-C5A7D692395AQ54294298-12D31697-61DB-4ED1-96D3-FDF84F6491DDQ54308605-D2B50264-F87D-4D45-B02B-4D2ED812633CQ55632531-24F3B45C-663A-4E33-9AE1-1DA89DE36C83
P2860
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The noninvestigational use of ...... patient safety and monitoring.
@ast
The noninvestigational use of ...... patient safety and monitoring.
@en
type
label
The noninvestigational use of ...... patient safety and monitoring.
@ast
The noninvestigational use of ...... patient safety and monitoring.
@en
prefLabel
The noninvestigational use of ...... patient safety and monitoring.
@ast
The noninvestigational use of ...... patient safety and monitoring.
@en
P2093
P2860
P50
P356
P1476
The noninvestigational use of ...... patient safety and monitoring
@en
P2093
Aubrey A Carhill
Camilo Jimenez
Maria E Cabanillas
Naifa L Busaidy
Rena Vassilopoulou-Sellin
Robert F Gagel
P2860
P356
10.1210/JC.2012-2909
P407
P577
2012-11-26T00:00:00Z